Abdominal Obesity Global Clinical Trials Review, H1, 2014

GlobalData
May 5, 2014
107 Pages - GLDATA18043
$2,500.00

Summary

GlobalData's clinical trial report, “Abdominal Obesity Global Clinical Trials Review, H1, 2014" provides data on the Abdominal Obesity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Abdominal Obesity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Abdominal Obesity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

'

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Abdominal Obesity 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Abdominal Obesity 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Abdominal Obesity Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Abdominal Obesity 32
Sep 30, 2013: Lithera Reports Positive Clinical Study Results From Its Phase 2b RESET Trial for LIPO-202, a Novel Treatment for Abdominal Body Contouring 32
May 07, 2013: Aileron Therapeutics Successfully Completes Stapled Peptide Clinical Trial 32
Mar 12, 2013: Lithera Initiates Phase IIb Clinical Trial Of LIPO-202 Targeting Aesthetic Reduction Of Subcutaneous Abdominal Fat 33
May 10, 2012: Theratechnologies Initiates Preclinical Safety Program For New GRF Peptide, TH1173 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Genfit SA 34
Clinical Trial Overview of Genfit SA 34
Lithera, Inc. 35
Clinical Trial Overview of Lithera, Inc. 35
AstraZeneca PLC 36
Clinical Trial Overview of AstraZeneca PLC 36
Sanofi 37
Clinical Trial Overview of Sanofi 37
Novartis AG 38
Clinical Trial Overview of Novartis AG 38
Hanmi Science Co., Ltd. 39
Clinical Trial Overview of Hanmi Science Co., Ltd. 39
Parry Nutraceuticals 40
Clinical Trial Overview of Parry Nutraceuticals 40
Kythera Biopharmaceuticals, Inc. 41
Clinical Trial Overview of Kythera Biopharmaceuticals, Inc. 41
Johnson & Johnson 42
Clinical Trial Overview of Johnson & Johnson 42
Clinical Trial Overview of Top Institutes / Government 43
Queen's University 43
Clinical Trial Overview of Queen's University 43
Massachusetts General Hospital 44
Clinical Trial Overview of Massachusetts General Hospital 44
University of Pittsburgh 45
Clinical Trial Overview of University of Pittsburgh 45
Wake Forest University 46
Clinical Trial Overview of Wake Forest University 46
Baker IDI Heart and Diabetes Institute 47
Clinical Trial Overview of Baker IDI Heart and Diabetes Institute 47
Rush University Medical Center 48
Clinical Trial Overview of Rush University Medical Center 48
UMC Utrecht Holding BV 49
Clinical Trial Overview of UMC Utrecht Holding BV 49
Southeast University 50
Clinical Trial Overview of Southeast University 50
Washington University School of Medicine 51
Clinical Trial Overview of Washington University School of Medicine 51
Maastricht University Medical Center 52
Clinical Trial Overview of Maastricht University Medical Center 52
Five Key Clinical Profiles 53
Appendix 105
Abbreviations 105
Definitions 105
Research Methodology 106
Secondary Research 106
About GlobalData 107
Contact Us 107
Disclaimer 107
Source 107

List of Tables
Abdominal Obesity Therapeutics, Global, Clinical Trials by Region, 2014* 7
Abdominal Obesity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Abdominal Obesity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Abdominal Obesity Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Abdominal Obesity Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Abdominal Obesity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Abdominal Obesity Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Abdominal Obesity Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Abdominal Obesity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Abdominal Obesity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Abdominal Obesity Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Abdominal Obesity Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Abdominal Obesity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Abdominal Obesity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Abdominal Obesity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Abdominal Obesity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Abdominal Obesity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2014* 34
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Lithera, Inc., 2014* 35
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 36
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 37
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 38
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Hanmi Science Co., Ltd., 2014* 39
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Parry Nutraceuticals, 2014* 40
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Kythera Biopharmaceuticals, Inc., 2014* 41
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 42
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2014* 43
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 44
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 45
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014* 46
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Baker IDI Heart and Diabetes Institute, 2014* 47
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2014* 48
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014* 49
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeast University, 2014* 50
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 51
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014* 52

List of Figures
Abdominal Obesity Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Abdominal Obesity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Abdominal Obesity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Abdominal Obesity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Abdominal Obesity Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Abdominal Obesity Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Abdominal Obesity Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Abdominal Obesity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Abdominal Obesity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Abdominal Obesity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Abdominal Obesity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Abdominal Obesity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Abdominal Obesity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Abdominal Obesity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 106

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax